glp 1 medication retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide—A Game Changer in Obesity
Description
This restriction means thousands of people who could benefit from evidence-based GLP-1 therapy must either pay out-of-pocket at pharmacy prices exceeding $1,000 monthly or remain untreated

Coverage details can vary by your specific plan, so we recommend verifying your benefits with us
You may need to obtain prior authorization first, though, depending on your medical history

New concepts on acute ocular ischemia
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
15 As such, GIP, secreted by enteroendocrine K-cells, and GLP-1, released from corresponding intestinal L-cells, collectively referred to as the incretin hormones, are well-studied for their roles in glucose homeostasis and energy balance

These medications work by mimicking the action of naturally occurring GLP-1 , a hormone released by the intestine in response to food intake